Established in 1923, Berger Paints is the amongst the largest paint manufacturers in India. The company manufactures and markets decorative & industrial paint products under various product brands. It has operations spread across India with seven man... More
ICI is a 51% subsidiary of ICI Plc. Although the company operates in 12 product lines which includes paints, pharmaceuticals, rubber chemicals, textile auxiliaries and polyurethane. Paints contribute to over 18% of total sales for ICI Limited. In lin... More
BERGER PAINTS | AKZO NOBEL | BERGER PAINTS/ AKZO NOBEL |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 140.9 | 50.2 | 280.5% | View Chart |
P/BV | x | 28.2 | 10.5 | 269.1% | View Chart |
Dividend Yield | % | 0.3 | 1.0 | 29.5% |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
BERGER PAINTS Mar-20 |
AKZO NOBEL Mar-19 |
BERGER PAINTS/ AKZO NOBEL |
5-Yr Chart Click to enlarge
|
||
High | Rs | 598 | 1,993 | 30.0% | |
Low | Rs | 292 | 1,471 | 19.9% | |
Sales per share (Unadj.) | Rs | 65.5 | 640.8 | 10.2% | |
Earnings per share (Unadj.) | Rs | 6.8 | 46.3 | 14.6% | |
Cash flow per share (Unadj.) | Rs | 8.7 | 60.6 | 14.4% | |
Dividends per share (Unadj.) | Rs | 2.20 | 24.00 | 9.2% | |
Dividend yield (eoy) | % | 0.5 | 1.4 | 35.7% | |
Book value per share (Unadj.) | Rs | 27.4 | 249.5 | 11.0% | |
Shares outstanding (eoy) | m | 971.22 | 45.54 | 2,132.7% | |
Bonus/Rights/Conversions | ESOP | BB | - | ||
Price / Sales ratio | x | 6.8 | 2.7 | 251.1% | |
Avg P/E ratio | x | 65.9 | 37.4 | 176.2% | |
P/CF ratio (eoy) | x | 51.0 | 28.6 | 178.6% | |
Price / Book Value ratio | x | 16.2 | 6.9 | 234.0% | |
Dividend payout | % | 32.6 | 51.8 | 62.9% | |
Avg Mkt Cap | Rs m | 432,047 | 78,875 | 547.8% | |
No. of employees | `000 | 3.6 | 1.7 | 212.4% | |
Total wages/salary | Rs m | 4,525 | 2,656 | 170.4% | |
Avg. sales/employee | Rs Th | 17,682.8 | 17,217.7 | 102.7% | |
Avg. wages/employee | Rs Th | 1,256.9 | 1,567.0 | 80.2% | |
Avg. net profit/employee | Rs Th | 1,822.5 | 1,244.8 | 146.4% |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 63,658 | 29,184 | 218.1% | |
Other income | Rs m | 685 | 422 | 162.4% | |
Total revenues | Rs m | 64,343 | 29,606 | 217.3% | |
Gross profit | Rs m | 10,610 | 3,424 | 309.9% | |
Depreciation | Rs m | 1,910 | 652 | 293.0% | |
Interest | Rs m | 470 | 45 | 1,045.3% | |
Profit before tax | Rs m | 8,915 | 3,149 | 283.1% | |
Minority Interest | Rs m | -83 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 7 | 0.0% | |
Tax | Rs m | 2,271 | 1,046 | 217.1% | |
Profit after tax | Rs m | 6,561 | 2,110 | 310.9% | |
Gross profit margin | % | 16.7 | 11.7 | 142.1% | |
Effective tax rate | % | 25.5 | 33.2 | 76.7% | |
Net profit margin | % | 10.3 | 7.2 | 142.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 25,865 | 14,102 | 183.4% | |
Current liabilities | Rs m | 17,066 | 8,845 | 192.9% | |
Net working cap to sales | % | 13.8 | 18.0 | 76.7% | |
Current ratio | x | 1.5 | 1.6 | 95.1% | |
Inventory Days | Days | 73 | 49 | 149.6% | |
Debtors Days | Days | 41 | 56 | 73.7% | |
Net fixed assets | Rs m | 22,299 | 5,470 | 407.7% | |
Share capital | Rs m | 971 | 456 | 213.0% | |
"Free" reserves | Rs m | 25,630 | 10,907 | 235.0% | |
Net worth | Rs m | 26,601 | 11,363 | 234.1% | |
Long term debt | Rs m | 2,434 | 29 | 8,392.4% | |
Total assets | Rs m | 49,050 | 20,979 | 233.8% | |
Interest coverage | x | 20.0 | 71.0 | 28.1% | |
Debt to equity ratio | x | 0.1 | 0 | 3,584.9% | |
Sales to assets ratio | x | 1.3 | 1.4 | 93.3% | |
Return on assets | % | 14.3 | 10.3 | 139.6% | |
Return on equity | % | 24.7 | 18.6 | 132.8% | |
Return on capital | % | 32.0 | 28.1 | 114.0% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 60 | 586 | 10.2% | |
Fx outflow | Rs m | 7,144 | 2,899 | 246.4% | |
Net fx | Rs m | -7,084 | -2,313 | 306.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 7,246 | 1,392 | 520.6% | |
From Investments | Rs m | -2,234 | 1,852 | -120.6% | |
From Financial Activity | Rs m | -4,794 | -3,600 | 133.2% | |
Net Cashflow | Rs m | 219 | -356 | -61.4% |
Indian Promoters | % | 60.5 | 0.0 | - | |
Foreign collaborators | % | 14.5 | 73.0 | 19.9% | |
Indian inst/Mut Fund | % | 2.6 | 9.7 | 26.8% | |
FIIs | % | 11.9 | 2.3 | 517.4% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 10.5 | 15.1 | 69.5% | |
Shareholders | 34,402 | 41,161 | 83.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare BERGER PAINTS With: SHALIMAR PAINTS KANSAI NEROLAC ASAHI SONGWON ASIAN PAINTS
Compare BERGER PAINTS With: PPG IND. (US) AKZO NOBEL (Netherland)
Indian share markets witnessed huge selling pressure today and extended losses as the session progressed, dragged down by heavy selling in metal and banking stocks.
Here's an analysis of the annual report of BERGER PAINTS for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of BERGER PAINTS. Also includes updates on the valuation of BERGER PAINTS.
For the quarter ended June 2020, BERGER PAINTS has posted a net profit of Rs 196 m (down 88.9% YoY). Sales on the other hand came in at Rs 9 bn (down 45.8% YoY). Read on for a complete analysis of BERGER PAINTS's quarterly results.
For the quarter ended December 2019, AKZO NOBEL has posted a net profit of Rs 770 m (up 27.5% YoY). Sales on the other hand came in at Rs 7 bn (down 7.2% YoY). Read on for a complete analysis of AKZO NOBEL's quarterly results.
For the quarter ended December 2019, BERGER PAINTS has posted a net profit of Rs 2 bn (up 37.9% YoY). Sales on the other hand came in at Rs 17 bn (up 4.9% YoY). Read on for a complete analysis of BERGER PAINTS's quarterly results.
For the quarter ended September 2019, AKZO NOBEL has posted a net profit of Rs 492 m (up 34.0% YoY). Sales on the other hand came in at Rs 6 bn (down 11.2% YoY). Read on for a complete analysis of AKZO NOBEL's quarterly results.
More Views on NewsWere you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
Our ace stock picker is ready to capitalise on a big growth opportunity.
The pandemic failed to thwart Richa's investing success formula for 2020.
More